| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| May 31, 2018 | May 31, 2018 | Morneau Michael VP Finance Administration | Sell | Viking Therapeutics, Inc. | VKTX | $9.25 | $199,347 | -18.64% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.